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Traumatic brain injury (TBI) leads to short-term and long-term consequences that 
can cause many different life-long disorders. Studies of TBI have generally focused on 
the acute stage; however, it is now becoming important to investigate chronic responses 
following TBI as clinical reports of dementia and cognitive impairments have been linked 
to a history of TBI. Recent data have established that cognitive function is associated 
with hippocampal neurogenesis. Chronic injury induced changes in the brain may affect 
this endogenous process. Chronic responses following TBI include cell death pathways 
and inflammatory responses that are persistent in the brain for months to years after 
injury. In this study we investigate the chronic consequences of TBI on adult 
neurogenesis and the possible involvement of chronic-inflammation in regulating adult 
neurogenesis. We used two popular TBI animal models, Control Cortical Impact (CCI) 
	 xiii	
and Lateral Fluid Percussion Injury (LFPI) models, to examine focal and diffuse injury 
responses respectively. Adult rats received CCI, LFPI, or sham injury and were sacrificed 
at either 15 days or 3 months after injury to examine either subacute or chronic TBI-
induced responses respectively. We found no change in levels of proliferation activity at 
both time points in both TBI models compared to sham animals. Using Doublecortin 
immunolabeling we found an enhanced generation of new neurons at 15 days after injury 
and by 3 months this activity was significantly reduced in both TBI models compared to 
sham animals. We also found persistent inflammation in the injured brains at both time 
points. Morphological assessment showed that LFPI model of TBI causes shrinkage of 
the ipsilateral hippocampus. Our results show that moderate TBI induced hippocampal 
neurogenesis in both models at the early time post-injury. However, at chronic stage, 
reduced hippocampal neurogenesis is observed in both models and this is accompanied 
by chronic inflammation. These results suggest that persistent inflammatory responses 
maybe detrimental to normal neurogenic activity, leading to cognitive impairment and 
neurodegeneration in long-term TBI survivors.   
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Chapter 1 - Introduction and Background 
Traumatic Brain Injury (TBI) is a major cause of death and life-long disability 
worldwide. It is defined as a physical insult to the brain, which disrupts normal brain 
functions and can be caused by a bump, blow, or jolt to the head (Marr and Coronado, 
2004). Various accidents such as car crashes, sports injuries, war related injuries, etc., 
could lead to TBI. Damaging factors of TBI can have acute and chronic consequences 
leading to many neurological disorders such as memory loss, behavioral dysfunction, 
epilepsy, dementia, and sleep disorders. 
 
Various animal models have been developed to study TBI. These models work by 
replicating specific aspects of a TBI to study acute and/or chronic injury mechanisms. 
Using various TBI animal models, many studies have shown an injury-induced up-
regulation in adult neurogenesis (Sun et al., 2005; Sun, 2016). These study have found an 
increase in proliferation of neural stem cells (NSC) and neural progenitor cells (NPC) in 
response to injury in the subventricular zone (SVZ) of the lateral ventricles and the 
dentate gyrus (DG) of the hippocampus (Dash et al., 2001; Rice et al., 2003). This 
neurogenic response after injury indicates that the brain has a limited ability to initiate 
mechanisms for repair and regeneration. Our lab has shown that injury-induced changes 
in hippocampal neurogenesis are related to innate cognitive recovery (Sun et al., 2015). 
Spontaneous cognitive recovery seen in many TBI patients may be a result of this 
endogenous neurogenic response.  
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Most TBI studies focus on acute and subacute changes after injury. However, 
there are growing number of clinical reports of long-term TBI patients that have 
developed neurodegenerative diseases and cognitive dysfunction (Mayeux et al., 1995; 
Castriotta et al., 2007). We hypothesize that neurodegeneration and cognitive dysfunction 
maybe a consequence of long-term injury-induced changes in adult neurogenesis. We 
suspect persistent secondary injury mechanisms of chronic-TBI such as 
neuroinflammation may be responsible for these neurogenic changes.  
 
Studies have shown that chronic-neuroinflammation can have a detrimental 
impact on adult neurogenesis (Fuster-Matanzo et al., 2013). In this study we used two 
popular TBI animal models, controlled cortical impact (CCI) injury and lateral fluid 
percussion injury (LFPI) models, to explore changes in adult neurogenesis in the chronic-
TBI stage and the association of these changes to neuroinflammation.  
 
Epidemiology  
  TBI affects millions of people worldwide every year. According to the Centers 
for Disease Control and Prevention (CDC), in the United States alone, 16% of all injury 
related emergency department (ED) visits are diagnosed as TBI. About 1.7 million people 
each year are affected by TBI in the United States. Many people that survive the injury 
develop life long disabilities. In the beginning of 2005 about 3.17 million people in the 
United States were living with long-term disability resulting from TBI (Zaloshnja et al., 
2008). In 2010 the economic burden of TBI was about $76.5 billion, not including TBIs 
managed in non-hospital locations and at federal institutions (Finkelstein et al., 2006). 
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Highest rate of TBI related hospitalizations and deaths occur in adults over 75 
years of age and 775,000 elderly adults develop life-long disabilities (Zaloshnja et al., 
2008). With pre-existing medical conditions and slower rates of functional 
improvements, elderly adults are more likely to have longer hospital stays and higher risk 
of mortality (Mosenthal et al., 2004; Thompson et al., 2006).  
 
The leading cause of TBI related ED visits is due to falls, and leading causes of 
TBI related deaths is motor vehicle accidents and suicides (Coronado et al., 2012). In 
2010, TBI caused about 50,000 total deaths, not accounting for people that did not 
receive medical care or people diagnosed at federal facilities (Faul et al., 2010). 
According to the Department of Defense, about 5.6 million United States military 
members from 2000 – 2011 were diagnosed with TBI (CDC, 2015). Combat situations 
that result in mild TBI may lead to increased risk of post-traumatic stress disorder 
(Bryant et al., 2010) which can further increase risk for various post-concussive 
symptoms (Brenner et al., 2010).  
 
Since 1980, hospitalization rate for mild TBI has significantly decreased due to 
improved safety and accident prevention programs whereas hospitalization rate for severe 
TBI has increased mainly due to improved availability and quality of medical treatments 
leading to greater survivability (Summers et al., 2009). This increase in survival rate 
leads to a greater number of people suffering from long-term disabilities after TBI. It is 
important to address these concerns of chronic-TBI by studying the mechanisms 
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regulating the spread of injury damages and developing treatments to reduce and/or 
reverse these damages.  
 
Biomechanics and mechanisms of TBI   
The cause of a TBI is a physical force that acts on the head resulting in structural 
damages and eventually causes damages to the brain at the cellular and biochemical 
levels. These cellular and biochemical changes then lead to cognitive and behavioral 
dysfunction. The underlying damages of a TBI can vary depending on the type and way 
injury is induced. The mechanical insults to the head can be characterized in three general 
categories: impact, impulse, and static. Impact occurs to the head with high magnitude 
and short duration of 50 ms or less causing deformation of the skull and brain tissue 
damage (Davis, 2000). Impulse occurs when there is a sudden change of head motion due 
to acceleration or deceleration of the body and does not involve deformation of the skull 
(Davis, 2000). Static involves long duration, greater than 200 ms of compressive force to 
the head causing skull deformation (Davis, 2000).  
 
The injuries caused to the brain tissue can be focal or diffuse. Focal injury occurs 
when the injury is focused on a particular area of the brain caused by a direct blow to the 
head and involves contusion, brain laceration, and hemorrhage (Gennarelli, 1993). 
Diffuse injury usually involves widespread microscopic damages caused by sudden head 
movement and involves concussion and diffuse axonal injury (Gennarelli, 1993).  
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The magnitude and duration of the mechanical force determines the extent of 
brain injury along with accompanying damages such as brain hemorrhage and swelling 
(Xiong et al., 2013). The resulting immediate damages are referred to as the primary 
injury. Besides the skull fracture and brain tissue damage, primary injury can also cause 
the initiation of secondary injury mechanisms (Xiong et al., 2013). Secondary injury 
involves non-mechanical damages such as increased intracranial pressure, reduced 
cerebral blood flow, blood brain barrier damage, bleeding, edema, diffuse axonal injury, 
cell death, and neurovascular damage (Xiong et al., 2015). A complex interplay of 
cellular and biochemical mechanisms such as excitotoxicity, mitochondrial damage, 
changes in gene expression, inflammatory responses, and oxidative stress are involved in 
the spread of secondary injury (Xiong et al., 2013). However, the onset of secondary 
injury mechanisms can happen seconds to months after injury, providing a therapeutic 
window of opportunity for treatment against the spread of damages after TBI.   
 
Pathology of TBI 
Physical damages to the brain can lead to long-term cognitive impairments and 
significantly increase chances of developing neurological diseases (Koponen et al., 
2002). Diffuse axonal injury serves as a clinical hallmark of human TBI and studies show 
that damage to white matter tracks correlate with declined cognitive function (Kraus et 
al., 2007). For example, using diffuse tensor imaging and neurophysiological testing, one 
study showed that TBI patients with greater white matter pathology had greater cognitive 
deficits (Kraus et al., 2007). Memory and attention are commonly impaired at all levels 
of TBI injury (Lovell and Franzen, 1994).  
	 6	
Cognitive deficits can have a devastating impact on social behavior and lifestyle, 
which also affects the lives of caregivers such as family and friends. Furthermore, 
behavioral changes in TBI patients may implicate the development of psychiatric 
disorders (Castriotta et al., 2007). Studies have reported that as many as half of TBI 
outpatients may be suffering from psychiatric disorders, and patients with pre-existing 
conditions have a higher likelihood of developing other disorders such as depression, 
anxiety, sleep disorders, and substance abuse (Koponen et al., 2002; Hibbard et al., 
1998). Disruption of the normal sleep cycle, causing various sleep disorders such as 
obstructive sleep apnea, posttraumatic hypersomnia, and narcolepsy, has also been linked 
to post-TBI consequences in about half of TBI outpatients (Castriotta et al., 2007). TBI 
also increases chance of death from other diseases. In some studies, TBI patients were 
more likely to die from seizures, septicemia, pneumonia, digestive disorders, and 
circulatory disorders compared to patients without a TBI history (Harrison-Felix et al., 
2006; Harrison-Felix et al., 2009; Shavelle et al., 2001).  
 
Surviving TBI patients often suffer from long-term neurological disorders such as 
epilepsy and dementia. There is a rising concern about the relationship between TBI and 
dementia. For example, TBI patients who have the ApoR E4 allele, which has been 
implicated in Alzheimer’s disease, are 10 times more likely to develop Alzheimer’s 
disease than healthy people (Mayeux et al., 1995). Studies have reported that TBI induces 
up-regulation or activation of certain biochemical mechanisms that have also been found 
to play a role in these degenerative diseases (Uryu et al., 2007). Although the detailed 
mechanisms of these processes are unclear, secondary injury mechanisms such as damage 
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to the blood brain barrier, free oxygen radicals causing oxidative stress, and other 
biochemical changes may be responsible for the onset of degenerative processes in the 
brain inducing dementia and other chronic diseases (Lye and Shores, 2000; Zhang et al., 
2000).   
 
Adult Neurogenesis 
In 1928 Ramon y Cajal proposed the idea that the brain loses the ability of growth 
and cellular regeneration after development (y Cajal, 1959). However, there is now 
overwhelming evidence indicating certain areas of the mammalian brain retain the ability 
to regenerate neural and glia cells. Evidence of adult neurogenesis in mammalian brain is 
largely found in rodent studies although it is also shown in many primate studies 
including humans (Rakic et al., 1985). 
 
The most active neurogenic regions in the adult mammalian brain are restricted to 
the SVZ of the lateral ventricles and the subgranular zone (SGZ) of the DG in the 
hippocampus (Lois and Alvarez-Buylla, 1993; Altman and Das, 1965). Some studies 
have also reported evidence of adult neurogenesis in the neocortex, striatum, and 
hypothalamus although these findings are controversial (Cameron and Dayer, 2008; 
Gould, 2007).  
 
The neurogenic process starts with the NSC proliferation, giving rise to more 
NSC and sometimes asymmetrically dividing into NPC, which are more determined to 
differentiate into either the neural or glial lineage (Gage, 2000). NSC division involves 
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both asymmetric and symmetric division. During asymmetric division, one NSC divides 
to produce one NSC and one NPC (Kriegstein and Alvarez-Buylla, 2009). Symmetric cell 
division can be proliferative, where one NSC divides into two identical NSCs, or 
differentative, where one NSC divides into two NPCs (Kriegstein and Alvarez-Buylla, 
2009). NPC then migrate to their destinations where they can differentiate and have 
functional potential. In the SVZ, most NPC migrate to the olfactory bulb, via the rostral 
migratory stream, where they differentiate into olfactory interneurons (Gritti et al., 2002). 
In the DG, migration is much more restricted, however, NPC do travel a short distance 
from the SGZ to the granular cell layer, where they can differentiate into granular 
neurons (Kempermann and Gage, 2000; van Praag et al., 2002). In both regions, 
migration of the cells and extension of dendrites and axons is guided by extracellular 
matrix molecules (Bovetti et al., 2007) and chemoattractive and repulsive molecules 
similar to migratory signaling pathways of development (Wu et al., 1999).  
 
In the DG, differentiation from NPC to mature functional granular neurons 
involves transition through several cell types. The proliferation stage of neurogenesis 
involves Type 1 and Type 2 progenitor cells. Type 1 cells, also called radial glial cells, 
divide slowly and asymmetrically into Type 2 cells, and Type 2 cells divide rapidly into 
more Type 2 cells or differentiate into neuroblasts (Bonaguidi et al., 2012). Neuroblasts 
then differentiate into immature neurons which, if allowed to survive, mature into 
granular neurons that extend their dendrites into the molecular layer and extend axons 
into the correct area of the CA3 region of the DG (Figure 1.1, Aimone et al., 2014; 
Hastings and Gould, 1999). 
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In both the SVZ and DG, pre-existing neurons are continuously replaced by 
newly generated neurons (Gage, 2000). In the DG, this amount of neuronal turnover 
varies in different regions such as the superficial granular cell layer, where 50% of the 
existing cells are replaced by late postnatal neurogenesis, and the deeper granular cell 
layer, where almost all pre-existing granular neurons are replaced (Imayoshi et al., 2008). 
The addition of these new neurons in the DG is significant enough to impact network 
function and has been shown to be important in normal cognitive function and behavior 
(Sun, 2016).  
 
During the maturation period of immature neurons, when they are undergoing 
morphological and physiological changes, their survival and potential for integration into 
the existing network is modulated by experience and on-going activity of the animal 
(Tashiro et al., 2007; Kee et al., 2007). Studies inhibiting adult neurogenesis in DG of 
rodents show that although inhibition may not cause depletion of existing neuron 
populations, it does retard the formation and integration of new neurons into the existing 
population which causes defects in spatial memory learning tasks such as Morris Water 
Maze (MWM) (Imayoshi et al., 2008; Jessberger et al., 2009). This supports the idea that 
the role of neurogenesis in the DG is for modulation of existing neural networks for 
hippocampal-dependent learning and memory functions, important during postnatal 
cognitive development.  
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Additionally, many studies show that cognitive function is affected by the level of 
adult neurogenesis which can be modulated by environmental experience, activity, and 
drugs, further confirming that adult neurogenesis plays an important role in hippocampal-
dependent learning and memory functions. Animals placed in enriched environment or 
given physical exercise show increased levels of granule cell proliferation and improved 
performance in spatial memory tasks such as MWM (Brown et al., 2003; Van et al., 
1999). Similar results have been found with exogenous administration of growth factors 
such as Basic Fibroblast Growth Factor (bFGF) (Wagner et al., 1999; Sun et al., 2009).  
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Figure 1.1. Adult neurogenic process in the dentate gyrus. Image extracted from 
Aimone et al., 2014. Proliferation step involves Type 1 cells asymmetrically dividing into 
neuroblasts by day three. By one week these neuroblasts become immature neurons, 
which then enter a survival period to mature into integrated granular neurons extending 
their dendrites into the molecular layer and axon into the CA3 region by 3-4 weeks.  
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TBI Induced Neurogenesis 
Modulation of adult neurogenesis has also been confirmed in TBI studies. This 
TBI stimulated endogenous neurogenesis is a natural response of the brain to promote 
repair (Sun, 2016). Although the exact mechanisms underlying the TBI-induced 
neurogenic response are unclear, studies have reported the up-regulation of growth 
factors such as Vascular Endothelial Growth Factor (VEGF), p75 NTR, bFGF, and 
Epidermal Growth Factor (EGF) following injury may regulate this process (Lee and 
Agoston, 2010; Catts et al., 2008; Sun et al., 2009; Sun et al., 2010). TBI animal models 
have shown increased proliferation of new cells in both the DG and SVZ (Dash et al., 
2001; Rice et al., 2003). In the DG, cell proliferation peaks at 2 days post-injury 
thereafter gradually declining and reaches baseline level at 14 days post-injury (Figure 
1.2, Sun et al., 2005). In terms of differentiation and survival of new neurons, studies 
have reported different results and these differences could be attributed to many different 
experimental factors such as different injury models or species used (Sun et al., 2007; 
Villasana et al., 2014). In the DG, almost half of all TBI-induced newly generated cells 
are able to survive to 10 weeks post-injury and most of these cells become mature 
neurons integrated into the functional hippocampal network, leading to cognitive 
recovery (Figure 1.3, Sun et al., 2007). In TBI animal studies, newly generated cells take 
about 14 days to fully mature and integrate into the functional network, which at that time 
animals begin to show cognitive recovery in MWM test, and by 60 days their 
performance is not significantly different from sham animals (Sun et al., 2007). This 
structural and functional recovery, via the neurogenic response of the brain following 
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injury, can be exogenously stimulated to promote regeneration and repair as a strategy for 
TBI treatment. 
 
Current developments for TBI treatment include different methods of further 
stimulating neurogenesis following injury. Exogenous administration of growth factors 
such as bFGF and EGF has shown increased proliferation in the DG and SVZ compared 
to untreated animals after injury (Sun et al., 2009; Sun et al., 2010). Similar treatments of 
other growth factors such as Insulin-like growth factor 1, brain-derived neurotrophic 
factor, VEGF, and S100B in injured animals have shown increased generation of new 
neurons and improved cognitive and functional recovery compared to untreated animals 
(Carlson et al., 2014; Gao et al., 2009; Thau-Zuchman et al., 2010; Kleindienst et al., 
2005). Pharmacological agents have also been developed to target post-TBI neurogenesis 
such as Cerebrolysin, 7,8-Dihydroxyflavone, LM11A-31, and carbamylated 
erythropoietin, showing increased neurogenesis with improved cognitive and functional 
recovery (Zhang et al., 2015; Chen et al., 2015; Shi et al., 2013; Xiong et al., 2011). 
Simple exercise such as running or putting animals in an enriched environment can also 
stimulate neurogenesis and improve recovery after injury (Gaulk et al., 2005; Piao et al., 
2013). 
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Figure 1.2. Proliferation timeline in the dentate gyrus. Results image extracted from 
Sun et al., 2005. The number of BrdU positive cells in the SGZ of the DG are shown at 2, 
7, and 14 days after injury. Animals received I.P. injections of BrdU at 2, 7, or 14 days 
after injury and were sacrificed 24 hours after the last injection. Injured juvenile and 
injured adult groups show peak proliferation at 2 days post injury and no difference in 
proliferation compared to sham animals at 14 days. Also, injured juveniles had almost 
twice the proliferation level as that of the adults at 2 days post injury.  
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Figure 1.3. New cells survive long time after injury. Results image extracted from Sun 
et al., 2007. Animals received I.P. BrdU injections at 5 days post injury. Injured animals 
show 4-fold increase of the number of BrdU cells at 5 days post injury. At 10 weeks post 
injury the number of BrdU cells was 3-fold higher than sham animals indicating that a 
significant number of BrdU cells survive even at 10 weeks post injury.  
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Animal models of TBI 
Our current understanding of TBI, mechanisms regulating damages, and 
development of potential treatments can be attributed to the use of animal models of TBI. 
To understand the heterogeneity of TBI, different animal models are in use that mimic 
specific aspects about the injury and resulting damages. These various models include 
fluid percussion injury (FPI), CCI, penetrating ballistic-like brain injury, weight-drop, 
Blast, and repeated mild TBI (Xiong et al., 2013). The most popular and widely used 
models are FPI and CCI.  
 
Since TBI can be caused in various situations including car accidents, sports, and 
military grounds, these models are set up to replicate primary and secondary injuries to 
the brain. For example, the FPI models are designed to replicate focal cortical contusion 
with diffuse subcortical neuronal injury, without skull fracture (Xiong et al., 2013). The 
CCI model is designed to replicate mostly focal injury mechanisms (O'Connor et al., 
2011). These models bypass the skull fracture, which allows for specific replication of 
injury aspects and control of injury parameters without randomized damages created by 
skull fragments. 
 
Both the CCI and FPI models allow for control of the injury causing parameters. 
In the FPI model, injury severity can be controlled by the height of the pendulum, which 
hits the fluid tube exerting a fluid pressure pulse to the brain (Kabadi et al., 2010). The 
CCI model has an advantage over the FPI model in that it allows for more control of 
parameters such as time, velocity, and depth of impact (O'Connor et al., 2011). 
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Nevertheless, both models have been successfully used to reproduce TBI and also to 
study the modulation of neurogenesis following injury.  
 
TBI-induced Neuroinflammation 
One of the several pathological conditions of TBI includes neuroinflammation. 
The complexity of many different molecular interactions and signaling pathways 
involved in neuroinflammation makes it difficult to elucidate the detailed mechanisms 
regulating this condition (Morganti-Kossmann et al., 2002). However, studies have 
reported that the immune system and central nervous system (CNS) resident glia cells are 
involved in inflammatory immune response after injury (Morganti-Kossmann et al., 
2007). Although the CNS is considered to be unaffected by the immune system, the 
disruption of the blood brain barrier after injury causes an increased expression of 
endothelial adhesion molecules and disruption of endothelial tight junctions leading to 
increased migration of immune cells such as leukocytes from systemic circulation into 
the brain parenchyma via interaction of endothelial adhesion molecules with integrins on 
the surface of leukocytes (Figure 1.4, Ziebell and Morganti-Kossmann, 2010; Morganti-
Kossmann et al., 2007). Tissue damage also triggers non-infection immune reactions that 
are activated by the release of damage associated molecular pattern molecules (DAMPs) 
from the injured tissue, which participate in the activation of the innate immune system 
(Matzinger et al., 1994; Manson et al., 2004). TBI-induced neuroinflammation, however, 
has been a controversial topic as studies suggest both beneficial and detrimental 
outcomes (Morganti-Kossmann et al., 2002).  
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Microgila, the resident immune cells of the CNS, are a major source of cytokine 
and chemokine release after injury. Conflicting evidence has been reported about the role 
of cytokines and chemokines, whether they promote repair functions or exacerbate the 
damages (Morganti-Kossmann et al., 2002). Enhanced tumor necrosis factor (TNF) levels 
in the brain after TBI has been associated with neurologic deficits, neuronal cell death, 
and blood brain dysfunction (Shohami et al., 1999). On the other hand, TNF knockout 
studies demonstrate that TNF may contribute to an early neurotoxic effect and a 
neuroprotective effect later in post-traumatic phase (Scherbel et al., 1999). TNF also 
triggers a rise in IL-6, which is a multifunctional factor that has anti-inflammatory 
effects, neurotrophic properties, induces nerve growth factor, promotes neuronal 
differentiation and survival, and counteracts excitotoxicity (Morganti-Kossmann et al., 
2001). This suggests that there is a feedback loop balancing the release of pro- and anti-
inflammatory cytokine release, further complicating the roles of these molecules 
(Morganti-Kossmann et al., 2002). IL-10, another anti-inflammatory cytokine, is well 
studied for its beneficial role in neuropathology and has also shown to diminish TNF 
synthesis (Morganti-Kossmann et al., 2000). However, a study in human TBI showed that 
high levels of IL-10 were associated with increased mortality (Bell et al., 1997). Other 
cytokines that have shown this dual nature include TGF-β, IFN-γ, and IL-18 (Fuster-
Matanzo et al., 2013). The complicated roles of these molecules may be a result of a 
complex interplay of molecular signaling and a fundamental importance of timing and 
concentration of their expression.  
 
Neuroinflammatory Effects on Neurogenesis 
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As for the effects of neuroinflammation on adult neurogenesis, whether it is 
beneficial or detrimental, seems to depend on the magnitude and duration of the 
inflammation (Fuster-Matanzo et al., 2013). Microglia play a critical role in the 
regulation and balance of these effects. In the normal uninjured brain, microglia regulate 
the balance of neurogenesis by releasing factors that instruct proliferated cells to 
differentiate into neurons, survival of immature neurons, or phagocytosis of apoptotic 
new cells (Sierra et al., 2010; Walton et al., 2006). Microglia are involved in releasing 
both anti-inflammatory and pro-inflammatory molecules providing pro-neurogenic and 
anti-neurogenic effects respectively (Fuster-Matanzo et al., 2013). However, there is 
strong evidence suggesting that chronic-inflammation leads to decreased neurogenesis 
through the accumulation of cytotoxic substances such as oxidative stress molecules and 
pro-inflammatory cytokines (Choi et al., 2009). Over-activation of microglia disturbs the 
homeostatic balance of pro- and anti-inflammatory cytokines inducing cell death 
pathways and leading to neurodegenerative diseases such Alzheimer’s and multiple 
sclerosis (Gao and Hong, 2008). Also, these apoptotic-mediating molecules are sustained 
long after TBI (Raghupathi et al., 2000). These effects have also been demonstrated in 
aging studies where aged mice have greater neurogenic deficits from neuroinflammation 
(Russo et al., 2011). Studies have shown that age is a critical factor that determines the 
level of endogenous neurogenesis as older animals show lower levels of neurogenesis 
(Sun et al., 2005).  
 
Although the immune response is a way for the body to restore homeostasis, after 
TBI, a sustained immune activation can ultimately lead to the blockage of restoration and 
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repair functions that otherwise could lead to a better outcome (Corps et al., 2015). These 
studies suggest that despite the initial benefits of inflammation after TBI, chronic 
inflammation may be detrimental to adult neurogenesis.  
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Figure 1.4. Immune system involvement in TBI. Image extracted from Ziebell and 
Morganti-Kossmann, 2010. Injury-induced blood brain barrier damage causes infiltration 
of leukocytes into the brain parenchyma via interaction of endothelial adhesion molecules 
with integrins on the surface of leukocytes, which can cause immune activation and 
inflammation in the brain.   
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Hypothesis  
In this study, we examine the differences in the neurogenic response following 
TBI in the subacute and chronic TBI stage using the CCI and LFPI models. Post-TBI 
cognitive decline or dementia is a significant issue. As hippocampal neurogenesis plays 
an important role in cognitive function, we speculate that TBI may have a long lasting 
effect on hippocampal neurogenesis, which may be affecting cognitive function. 
Specifically, we propose that in the chronic TBI stage there is a decline of neurogenesis 
below the baseline level and this decline is due to either the exhaustion of the NSC pool, 
from over stimulation of symmetrical differentiative divisions during neurogenesis, or 
persistent neuroinflammation.  
 
Because TBI is such a complex and complicated neurological disorder with 
impact on other neurological diseases, it is difficult to study TBI using one animal model. 
Since TBI encompasses a vast array of complex mechanisms and each type of animal 
model is used to study specific aspects of TBI, it is practical to use multiple different 
animal models when studying TBI and treatments. However, in terms of studying TBI-
induced neurogenesis, there are no studies that compare the levels of injury-induced 
neurogenesis among different animal models. In this study we used two popular TBI 
animal models, CCI injury and LFPI models, to study focal and diffuse injuries responses 
respectively.  
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Chapter 2 - Materials and Methods 
Experimental Animals 
All animals used in this study were 3 months old male Sprague-Dawley rats that 
weighed around 300g and were purchased from Harlan Inc., Indiana. A total of 25 rats 
were included in this study. All animals were housed in pair at the Virginia 
Commonwealth University animal care facility and were given a 12 hour light/dark cycle 
at room temperature with adequate food and water ad libitum. Proper maintenance and 
animal care procedures were followed, which were approved by the Institution of Animal 
Care and Use Committee (IACUC) of Virginia Commonwealth University and the Guide 
for Care and Use of Laboratory Animals by the U.S. Department of Health and Human 
Services.  
 
Experimental Setup  
Animals were divided into two groups. Group one included 15 total rats and 
group two included 10 total rats. All animals received the same housing and care. Group 
one animals included four animals that received LFPI, seven animals that received CCI 
injury, and four sham animals. All group one animals were sacrificed 15 days after 
injury. Group two animals included four LFPI animals, four CCI injury animals, and two 
sham animals. All group two animals were given one BrdU injection 2 hours before 
sacrifice and were sacrificed 3 months after injury. The experimental set up is also 
described in Table 2.1. 
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Table 2.1. Experimental Setup 
 Group 1 Group 2 
Sham 4 Rats 2 Rats 
LFPI 4 Rats 4 Rats 
CCI 7 Rats 4 Rats 
Sacrifice Time After Injury 15 Days 3 months 
BrdU Administration  2 Hours before 
sacrifice 
Immunostaining DCX, Ki67, 
OX6, ED1 
DCX, Ki67, BrdU, 
OX6, ED1 
Hippocampus Size 
Comparison 
 Cresyl violet 
stained sections 
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Table 2.1. Experimental setup. Animals were divided between Group 1 and Group 2. 
Group 1 includes 4 shams, 4 LFPI, and 7 CCI rats, which were sacrificed 15 days after 
injury. Hippocampal sections of these rat brains were used for DCX, Ki67, OX6, and 
ED1 immunostaining. Group 2 included 2 shams, 4 LFPI, and 4 CCI rats, which received 
BrdU injections 2 hours before sacrifice and were sacrificed 3 months after injury. 
Hippocampal sections of these rat brains were used for DCX, Ki67, BrdU, OX6, and ED1 
immunostaining as well as hippocampal size comparison.  
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Surgical procedures  
Animals were randomly assigned to receive LFPI, CCI, or Sham injuries. Before 
surgery, all surgical tools and instruments were sterilized and aseptic procedures were 
followed during surgery. Animals were first put in a Plexiglas chamber with 5% 
isoflurane to be anesthetized. Once the animal was unconscious, the animal’s head was 
shaved to remove excess fur. Then the animal’s head was fixed in a stable position in a 
stereotaxic apparatus while the animal was intubated and kept anesthetized throughout 
surgery with 2.5% isoflurane in a gas mixture of 30% O2 and 70% N2. Betadine was 
applied to sterilize the head at the surgical site. Paralube ointment was applied to both 
eyes of the animal to prevent the eyes from drying. Using a scapula, a midline incision 
was made on the head and hemostats were used to retract the skin on both sides of the 
head to expose the skull. Connective tissue was removed by rubbing the skull with 
sterilized cotton tip applicators. A 4.0 mm craniotomy was made half way between the 
lambda and bregma sutures on the left parietal bone using a trephine and a Dremel drill 
fitted with a small dental drill bit. After cutting the bone, it was removed and any bone 
shards were removed from the craniotomy. All animals, including shams received the 
above surgical procedures. For LFPI and CCI injury animals, appropriate injuries were 
performed as described below. After surgery, the surgical incision was sutured in a 
simple continuous pattern using a sterilized stainless steel suture needle and a 5-0 
polyamide surgical suture. Lidocaine hydrochloride jelly, which is a local anesthetic, and 
a triple antibiotic ointment were applied to the closed suture. Then, the isoflurane was 
turned off and intubation was removed. The animal was monitored until it regained 
normal breathing pattern. The animal’s cage was lined with surgical drape and once the 
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animal righted, it was placed back into the cage and observed for three hours before 
returning to the animal housing facility.  
 
Lateral Fluid Percussion Injury 
A total of 8 animals received LFPI in this study. After the craniotomy, a Luer lock 
hub was cemented over the craniotomy using cyanoacrylic. Dental acrylic was used to 
seal the base around the hub and allowed to dry. To test the seal, the hub was filled with 
0.9% saline solution, which also served as a medium for the injury pulse from the FPI 
device. Then, for 4 minutes, the isoflurane rate was reduced to 1%. During this time the 
FPI device (Figure 2.1, Thompson et al., 2005) was prepared by measuring the height of 
the pendulum that was needed to produce the target pressure pulse. This was done by 
calibrating the device by repeated test uses to produce pressure pulses around a target 
value of 2.0 atm. The pressure was measured by an oscilloscope (Tektronix) and a 
pressure transducer amplifier, which were connected to the FPI device. The isoflurane 
was turned off and the Luer lock hub on the animal was connected to the injury device 
and the injury was administered. Then the hub was disconnected from the injury device 
and the animal was returned to the surgical preparation area. The Luer lock hub and 
acrylic base were detached from the animal’s head and the animal was placed on the 
surgical mat. The animal was observed until it righted and the righting time was recorded. 
Once the animal regained normal breathing, it was placed back on to the stereotaxic 
frame and was anesthetized with 5% isoflurane before the surgical site was sutured.  
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Figure 2.1. Lateral fluid percussion injury setup. (A) All injuries were made on the 
left hemisphere in the middle of bregma and lambda sutures as represented in this image. 
(B) This cartoon depicts the LFPI device used in this study and the position of the animal 
during injury.  
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Controlled Cortical Impact Injury 
A total of 11 animals received CCI injury in this study. After the craniotomy, 
animals were kept anesthetized. A Leica Benchmark Stereotaxic Impactor was connected 
to the stereotaxic frame (Figure 2.2, Galgano et al., 2015). The 3 mm rigid impactor tip 
was positioned above the craniotomy and the zero point of impact was obtained by 
lowering the tip of the impactor until it touched the dura mater. The tip was driven by an 
electromagnetic piston and moved at 4 m/sec and remained on the tissue for 500 ms. A 
2.5 mm depression in the tissue was set to cause a moderate level of focal injury. After 
the tip retracted, it was raised away from the animal. The animal was then sutured and 
monitored for normal breathing before returning to home cage.  
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Figure 2.2. CCI device.  Photographs representing the (A) Controlled Cortical Impact 
injury device and (B) position of the animal during injury.  
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BrdU injections 
BrdU (Sigma-Aldrich Co.), a thymidine analog that incorporates into DNA during 
cell division, is used to permanently label dividing cells. Group 2 animals received one 
dose (50 mg/kg of body weight) via intraperitoneal (I.P.) injection at 2 hours before 
sacrifice.  
 
Sacrifice and Tissue Processing  
Group one animals were sacrificed 15 days after injury while group two animals 
were sacrificed 3 months after injury. Each animal was placed in a Plexiglas chamber 
with 5% isoflurane and deeply anesthetized. The animal was taken out and a surgical 
gauze pad soaked in 100% isoflurane was placed on the animals nose to keep it 
anesthetized while it was transcardially perfused with 400 mL phosphate-buffered saline 
(PBS) and then with 400 mL of 4% paraformaldehyde in PBS fixative. The brains were 
removed and stored at 4°C in 4% paraformaldehyde in PBS fixative. After 48 hours, the 
brains were sliced into 60 µm coronal sections using a vibratome (Leica). The sections 
were stored in 24 well plates filled with 0.01% sodium azide in PBS and stored at 4°C. 
Brain sections were used as needed for different immunostaining protocols.  
 
BrdU Immunostaining 
Six sequential hippocampal brain sections from each brain of group two animals 
were selected for BrdU immunostaining. Sections were first washed in 1X PBS two times 
for five minutes each. Then they were incubated in a denatured solution with 50% 
formamide, 37.5% H2O, and 12.5% 20X saline sodium citrate (SSC) buffer for one hour 
	 38	
at 65°C. Then the sections were rinsed in 2X SSC two times for 5 minutes each, and 
further denatured in 2N hydrochloric acid for 30 minutes at 37°C. Then they were rinsed 
with 1X PBS two times for 5 minute each, and placed in 3% hydrogen peroxide for one 
hour. The sections were then rinsed with 0.3% Triton X-100 in 1X PBS (washing buffer) 
for 10 minutes and placed in 5% normal horse serum in washing buffer (blocking buffer) 
overnight at 4°C. Then the sections were placed in the BrdU antibody solution for 48 
hours at 4°C. The antibody solution was prepared with monoclonal mouse anti-BrdU 
antibody (Dako) diluted in blocking buffer at a 1 to 200 dilution. The sections were then 
allowed to come back to room temperature and rinsed in washing buffer three times for 
10 minutes each, before placing them in blocking buffer for three hours at room 
temperature. Then the sections were placed in secondary antibody solution overnight at 
4°C. This solution was prepared with the Biotin-conjugated anti-mouse IgG antibody 
(Vector) diluted in blocking buffer at a 1 to 200 dilution. The sections were then allowed 
to come back to room temperature and rinsed in washing buffer three times for 10 
minutes each, before placing them in Avidin-biotin Complex reagent for two hours at 
room temperature. This solution was prepared 30 minutes before use from the Avidin-
biotin Complex kit (Vector Labs, Burlingame, CA) and diluted in 1X PBS at a 1 to 200 
dilution. Then the sections were rinsed in washing buffer three times for 10 minutes each, 
before placing them in 3,3’ diaminobenzadine tetra-hydrochloride (DAB) (Sigma) 
solution. Once the sections were properly stained by the reaction, which was noted by 
visible stained cells under the microscope, the sections were rinsed with 1X PBS three 
times and mounted onto glass slides and allowed to air dry. Then they were 
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counterstained with 0.1% cresyl violet, dehydrated through gradient ethanol and cover 
slipped with Permount.  
 
DCX, Ki67, OX6, ED1 Immunostaining 
Sequential brain sections of all animals were processed for Doublecortin (DCX), 
Ki67, OX6, and ED1 immunostaining. Similar steps were taken as described in BrdU 
immunostaining, with the exception of denaturing procedure. After sections were rinsed 
with PBS, they were directly placed in 3% hydrogen peroxide solution for one hour, 
thereafter, BrdU immunostaining protocol was followed. For DCX immunostaining, the 
primary antibody solution was prepared with polyclonal goat anti-DCX (1:1000, Santa 
Cruz) and the secondary antibody solution was prepared with the Biotin-conjugated anti-
goat IgG antibody (1:200, Vector). For Ki67 immunostaining, the primary antibody 
solution was prepared with rabbit anti-Ki67 (1:500, Abcam) and the secondary antibody 
solution was prepared with Biotin-conjugated anti-rabbit IgG antibody (1:200, Vector). 
For OX6 immunostaining, the primary antibody solution was prepared with mouse anti 
rat MHC Class II OX6 antibody (1:1000, AbD Serotec) and the secondary antibody 
solution was prepared with the Biotin-conjugated anti-mouse IgG antibody (1:200, 
Vector). For ED1 immunostaining, the primary antibody solution was prepared with 
mouse anti rat ED1 (1:1000, AbD Serotec) and the secondary antibody solution was 
prepared with the Biotin-conjugated anti-mouse IgG antibody (1:200, Vector).  
 
Densitometry 
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The intensity of OX6 and ED1 staining was quantified by densitometry analysis 
using Image J program. Briefly, images of selected regions of OX6 or ED1 stained 
section was taken using the 4x objective on an inverted light microscope (1X71, 
Olympus) and Olympus controller program. Images were taken with automatic adjusted 
white balance, and exposure was set to produce the best image. Exposure was kept same 
for all sections of animal brains to be compared. ImageJ program was used to measure 
the optical density of the staining in a selected region of interest at a 0.621 pixels/um 
scale. The images were first converted to a RGB stack image. The threshold for detection 
was determined by selecting automatically according to the image exposure. For each 
brain, two sections were used and the average of measurements was taken. Measurements 
were recorded as percentage of selected area stained.  
 
Stereology 
All stained hippocampal sections were observed under an inverted light 
microscope (1X71, Olympus) microscope for quantifying the number of stained cells. For 
all cell counting, the Visiopharm program (Olympus) was used. First, a 4x objective was 
used to outline the region of interest. The stereological optical fractionator method was 
used to count the number of stained cells in the outlined region. For Ki67 and BrdU 
stained sections, the granular zone (GZ), which includes the SGZ and granular cell layer 
(GCL), were outlined. For DCX stained sections, cells were separately counted in the 
SGZ plus inner 1/3 GCL, middle 1/3 GCL, and outer 1/3 GCL. To derive the total DCX 
positive cell count of the GZ, cell counts of following three regions were added: the SGZ 
plus inner 1/3 GCL, middle 1/3 GCL, and inner 1/3 GCL. For Brdu, Ki67, and DCX 
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sections, stained cells were also counted in the hilus region. Cells outside of the optical 
dissector counting frame were omitted. The dissector height (h) was set to 15 µm. 
Measuring the focal plane at five different locations on each section and then taking the 
average, the average thickness (t) of each brain section was calculated. These averages 
were then averaged for the total five sections per brain. Total cell counts (n) were 
estimated to be n= ΣQ ¯· (t/h)(1/asf)(1/ssf), were ΣQ ¯ represents the number of counted 
cells. asf is the average sampling fraction and because the entire region was counted in 
these sections, it is set to one. ssf is the sample sectioning fraction and it is set to 0.125 
because five sections were used from each brain, representing 1/8 of the total 
hippocampus.  
 
Hippocampal Size 
To examine the injury-induced change of the hippocampus size, the ipsilateral and 
contralateral hippocampal perimeters were measured using the Visiopharm program. 
Cresyl violet stained sections from group two animal brains were observed under the 
light microscope. The ipsilateral and contralateral hippocampi were separately outlined 
using a 4X objective and perimeter of the outline was obtained. Due to inter-animal 
variability of brain structures, we compared ipsilateral to contralateral hippocampi within 
the same animal by taking a percent ratio of ipsilateral to contralateral hippocampal 
perimeters. For each animal brain, 5 sections were used and their measurements were 
averaged to calculate the hippocampal size percent change of each animal.  
 
Statistical Analysis 
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We performed One-Way ANOVA using SPSS software to determine statistical 
significant difference of three injury groups, sham, CCI injury, and LFPI, in all 
experiments. To compare pairwise statistical significance of any two groups, we 
performed a post hoc Fisher Least Significant Difference (LSD) test. A p value of 0.05 or 
less was considered statistically significant.  
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Chapter 3 - Results 
The purpose of this study was to evaluate the differences in TBI-induced 
neurogenic responses in subacute and chronic-TBI using different TBI animal models. 
Two popular TBI animal models, CCI and LFPI, were compared at two different injury 
time points, 15 days after injury and 3 months after injury. The degree of neurogenic 
difference was evaluated by comparing levels of proliferation, generation of new 
neurons, and neuroblast migration after injury in the DG.  
 
Experiment 1. TBI-Induced Subacute and Chronic Proliferation 
We used the cell proliferation markers Ki67 and BrdU to identify newly 
proliferating cells after injury in three groups: sham, CCI, and LFPI groups. Ki67 is a 
popular marker for proliferating cells because during interphase the Ki67 protein is 
located in the nucleus whereas during the mitotic cell phases it is relocated to the surface 
of the chromosomes where it can be detected by Ki67 antibodies (Scholzen and Gerdes, 
2000). We also used BrdU, which is a thymidine analogue that incorporates into 
replicating DNA during the S phase of cell cycle, taking place of thymidine, and can later 
be detected by BrdU antibodies in cells that were proliferating during the time of BrdU 
incorporation (Kee et al., 2002). 
 
Proliferative responses in Subacute-TBI 
At 15 days after injury, we observed similar proliferative levels in all three groups 
(Figure 3.1) and stereological quantification demonstrated that the number of Ki67 
positive cells between the three groups in the granular zone and hilus regions of the DG 
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remained relatively similar (Figure 3.2). This was true for both ipsilateral and 
contralateral side. We used One-Way ANOVA to compare statistical significant 
difference of all three groups and found no significant difference in the ipsilateral GZ 
(p=0.325), ipsilateral hilus (p=0.465), contralateral GZ (p=0.826), and contralateral hilus 
(p=0.376) regions of the three groups.  
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Figure 3.1. Cell proliferation at 15 days after injury. Images of a coronal section of 
Sprague Dawley rat brain showing Ki67 staining pattern of the ipsilateral dentate gyrus. 
The arrows indicate Ki67 positive cells. Using the (A) 4X objective the entire staining 
pattern of the dentate gyrus can be seen and using the (B) 40X objective the individual 
stained cells are identified. This staining pattern is consistent in all injury groups 
indicating similar levels of proliferation.   
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Figure 3.2. Quantification of Ki67 positive cells at 15 days after injury. The number 
of Ki67 positive cells in the dentate gyrus of ipsilateral and contralateral sides of the 
injury were quantified in the sham, CCI, and LFPI injury groups. At 15 days after injury, 
the level of proliferation in the (A) GZ was not significantly different in injured groups 
from sham animals. This was also true for proliferation levels in the (B) hilus region.  
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Proliferative responses in Chronic-TBI 
To understand long-term effects of TBI on adult neurogenesis, we examined the 
level of proliferation at 3 months after injury. In our results, we did not observe a 
difference in the level of proliferation in injured animals compared to sham animals at 3 
months after injury (Figure 3.3). Stereological quantification analysis using One-Way 
ANOVA demonstrated that there was no significant difference in the levels of Ki67 
positive cells in the ipsilateral (IP) and contralateral (CT) dentate gyrus of injury and 
sham animals (IP: GZ p=0.838, hilus p=0.605; CT: GZ p=0.885, hilus p=0.785) (Figure 
3.4). To further verify these findings, we used another cell proliferation marker, BrdU, to 
label proliferating cells, and also found no difference in proliferation in sham and injured 
groups. Stereological quantification analysis demonstrated that there was no significant 
difference in the levels of BrdU positive cells in the ipsilateral (IP) and contralateral (CT) 
dentate gyrus of injury and sham animals (IP: GZ p=0.438, hilus p=0.143; CT: GZ 
p=0.627, hilus p=0.371) (Figure 3.5). 
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Figure 3.3. Cell proliferation at 3 months after injury. Images of coronal sections of 
Sprague Dawley rat brain showing Ki67 and BrdU staining patterns of the ipsilateral 
dentate gyrus. The arrows indicate stained positive cells. Using the (A) 4X objective, the 
Ki67 staining pattern of the entire dentate gyrus can be seen and using the (B) 40X 
objective the individual stained cells are identified. The observed Ki67 staining pattern is 
consistent in sham, CCI injury, and LFPI animals, indicating similar levels of 
proliferation. Immunolabeled images of BrdU staing using (C) 4X objective to show the 
entire dentate gyrus and (D) 40X objective to show individual stained cells also indicate 
consistent proliferation levels in sham, CCI injury, and LFPI animals. 
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Figure 3.4. Quantification of Ki67 positive cells at 3 months after injury. The number 
of Ki67 positive cells in the dentate gyrus of ipsilateral and contralateral sides of the 
injury were quantified in the sham, CCI, and LFPI injury groups. At 3 months after 
injury, the level of proliferation in the (A) GZ was not significantly different in injured 
groups from sham animals. This was also true for proliferation levels in the (B) hilus 
region. 
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Figure 3.5. Quantification of BrdU positive cells at 3 months after injury. The 
numbers of BrdU positive cells in the ipsilateral and contralateral dentate gyrus were 
quantified in the sham, CCI, and LFPI injury groups. At 3 months after injury, the level 
of proliferation in the (A) GZ was not significantly different in injured groups from sham 
animals. This was also true for proliferation levels in the (B) hilus region. 
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Experiment 2. TBI-Induced Generation of New Neurons 
After proliferation, surviving cells in neurogenic regions differentiate into either 
neuronal or glial cell lineage. Cells that become determined for a neuronal lineage 
express certain biomarkers including DCX. To determine the impact of TBI on the 
generation of new neurons, we used the DCX antibody to label newly generated neurons. 
DCX is a microtubule binding protein expressed in immature neurons and migrating 
neuroblasts in neurogenic regions of the adult mammalian brain (Brown et al., 2003). We 
compared levels of newly generated neurons at 15 days after injury and 3 months after 
injury in the DG of animals that received sham, CCI, or LFPI injury.  
 
Generation of New Neurons in Subacute-TBI 
In our results, we observed an increase in the number of newly formed neurons at 
15 days after injury in the ipsilateral dentate gyrus of the injured animals compared to 
sham animals (Figure 3.6). We used One-Way ANOVA to compare significant 
difference of all three groups and found statistically significant difference of the levels of 
DCX positive cells in the ipsilateral GCL (p=0.002) and ipsilateral hilus region (p=0.001) 
(Figure 3.7). We used a post hoc LSD test to determine pair wise significance of the 
group means, which revealed that although there was a significant increase of DCX 
positive cells in the ipsilateral GCL of injured animals compared to sham (sham vs. CCI, 
p=0.001; sham vs. LFPI, p=0.015), there was no significant difference between the CCI 
injury and LFPI groups (p=0.061). In the ipsilateral hilus region, a pairwise comparison 
of each injury group to sham showed significant increase of DCX positive cells (sham vs. 
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CCI, p<0.001; sham vs. LFPI, p=0.03) and CCI injury animals had significantly more 
DCX positive cells than LFPI animals (p=0.005).  
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Figure 3.6. Generation of new neurons at 15 days after injury. Images of a coronal 
section of Sprague Dawley rat brain showing DCX staining pattern of the ipsilateral 
dentate gyrus. The arrows indicate DCX positive cells. In (A) sham animals, there is less 
observable DCX staining compared to (B) CCI injury and (C) LFPI. To determine 
neuronal migration, (D) the GZ was divided into three regions, the SGZ and 1/3 of the 
inner GCL, middle 1/3 of the GCL, and outer 1/3 of the GCL as shown.  
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Figure 3.7. Quantification of DCX positive cells at 15 days after injury. In the (A) 
ipsilateral GZ, both types of injuries resulted in significantly higher level of DCX 
positive cells indicating more generation of new neurons compared to sham animals 
(sham vs. CCI, p=0.001; sham vs. LFPI, p=0.015).  In the (B) ipsilateral hilus region, 
both types of injuries resulted in significantly higher level of DCX positive cells 
compared to sham animals (sham vs. CCI, p<0.001; sham vs. LFPI, p=0.03), and the CCI 
injury had a significantly higher number DCX positive cells compared to LFPI (p=0.005) 
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Differences in neuronal migration was determined by using the Visiopharm 
program to trace and divide the GZ into 3 regions, the SGZ plus inner 1/3 GCL, middle 
1/3 of the GCL, and outer 1/3 of the GCL, and count the number of DCX positive cells in 
each region (Figure 3.6). Stereological quantification demonstrated that both types of 
injuries induced an increased number of DCX positive cells in the ipsilateral SGZ plus 
inner 1/3 GCL, but only CCI injury induced an increase of DCX positive cells in the 
ipsilateral middle 1/3 of the GCL, and ipsilateral outer 1/3 of the GCL. Using a post hoc 
LSD test to compare pairwise significance, we found that in the SGZ plus inner 1/3 GCL, 
each type of injury compared to sham had a statistically significant increase in DCX 
positive cells (sham vs. CCI, p=0.005; sham vs. LFPI, p=0.021), but there was no 
significant difference between CCI and LFPI groups (p=0.418) (Figure 3.8). In the 
ipsilateral middle 1/3 GCL, we found that CCI injury produced a statistically significant 
increase in DCX positive cells compared to sham and LFPI (sham vs. CCI, p<0.001; CCI 
vs. LFPI, p<0.001), but there was no significant difference between sham and LFPI 
groups (p=0.52) (Figure 3.8). In the ipsilateral outer 1/3 GCL, we found the same pattern 
of increase in DCX positive cells where CCI injury produced a statistically significant 
increase compared to sham and LFPI (sham vs. CCI, p=0.034; CCI vs. LFPI, p=0.021), 
but there was no significant difference between sham and LFPI groups (p=0.948) (Figure 
3.8).  
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Figure 3.8. Migration of neuroblasts at 15 days after injury. In sham and injured 
animals, majority of the DCX positive cells of the GZ were located in the (A) SGZ plus 
inner 1/3 GCL, with a significantly higher number of DCX positive cells in injured 
animals compared to sham (sham vs. CCI, p=0.005; sham vs. LFPI, p=0.021) and no 
significant difference between CCI injury and LFPI groups (p=0.418). In the (B) middle 
1/3 GCL, CCI injury resulted in a significantly higher number of DCX positive cells 
compared to sham and LFPI (sham vs. CCI, p<0.001; sham vs. LFPI, p=0.52; CCI vs. 
LFPI, p<0.001). Also in the (C) outer 1/3 GCL, CCI injury resulted in a significantly 
higher number of DCX positive cells compared to sham and LFPI (sham vs. CCI, 
p=0.034; sham vs. LFPI, p=0.948; CCI vs. LFPI, p=0.021). 
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Generation of New Neurons in Chronic-TBI 
To further evaluate long-term effects of TBI on adult neurogenesis, we examined 
the generation of new neurons at 3 months after injury by DCX immunolabeling. In our 
results, we observed a decrease in the number of newly formed neurons at 3 months after 
injury in the ipsilateral and contralateral DG of the injured animals compared to sham 
animals (Figure 3.9). Stereological quantification analysis demonstrated that injured 
animals and sham animals had statistically different levels of DCX positive cells in the 
ipsilateral GZ (p=0.002), contralateral GZ (p=0.016), and ipsilateral hilus region 
(p=0.001) (Figure 3.10). Although we saw an observable difference between the three 
groups in the contralateral hilus region, the data was not statistically different. A pairwise 
comparison using post hoc LSD between two groups reveled that there was a significant 
decrease of DCX positive cells in the ipsilateral and contralateral GZ of injured animals 
compared to sham (IP: sham vs. CCI p=0.001, sham vs. LFPI p=0.002; CT: sham vs. 
CCI p=0.009, sham vs. LFPI p=0.013), however, there was no significant difference 
between the CCI injury and LFPI groups (IP: p=0.781; CT: p=0.823) (Figure 3.10). In 
the ipsilateral hilus region, a pairwise comparison of each injury group to sham revealed 
a statistically significant decrease of DCX positive cells in animals that received LFPI 
(sham vs. LFPI, p=0.006) but not in animals that received CCI injury (sham vs. CCI, 
p=0.118) (Figure 3.10). There was also no statistical difference between the two types of 
injuries (CCI vs. LFPI, p=0.097).  
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Figure 3.9. Generation of new neurons at 3 months after injury. Images of a coronal 
section of Sprague Dawley rat brain showing DCX staining pattern of the ipsilateral 
dentate gyrus. The arrows indicate DCX positive cells. In (A) sham animals, there are 
more observable DCX stained cells compared to (B) CCI injury and (C) LFPI.  
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Figure 3.10. Quantification of DCX positive cells at 3 months after injury. In the (A) 
ipsilateral and contralateral GZ, both types of injuries resulted in significantly lower 
levels of DCX positive cells indicating less generation of new neurons compared to sham 
animals (IP: sham vs. CCI p=0.001, sham vs. LFPI p=0.002; CT: sham vs. CCI p=0.009, 
sham vs. LFPI p=0.013).  In the (B) ipsilateral hilus region, animals that received LFPI 
resulted in significantly lower level of DCX positive cells compared to sham animals 
(sham vs. LFPI, p=0.006). 
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Differences in neuronal migration were determined by dividing the GZ into 3 
regions as previously described (Figure 3.6). Stereological quantification demonstrated 
that both types of injury groups had reduced number of DCX positive cells in the 
ipsilateral and contralateral SGZ plus inner 1/3 GCL and middle 1/3 GCL compared to 
sham. Using a post hoc LSD pairwise comparison, in the ipsilateral and contralateral 
SGZ plus inner 1/3 GCL, we found that each type of injury compared to sham had a 
statistically significant decrease in DCX positive cells (IP: sham vs. CCI p=0.001, sham 
vs. LFPI, p=0.002; CT: sham vs. CCI p=0.011, sham vs. LFPI, p=0.018), but there was 
no significant difference between CCI and LFPI groups (IP: CCI vs. LFPI p=0.676; CT: 
CCI vs. LFPI p=0.782) (Figure 3.11). In the ipsilateral and contralateral middle 1/3 
GCL, we also found that each type of injury compared to sham had a statistically 
significant decrease in DCX positive cells (IP: sham vs. CCI p=0.011, sham vs. LFPI, 
p=0.001; CT: sham vs. CCI p=0.026, sham vs. LFPI, p=0.008), but there was no 
significant difference between CCI and LFPI groups (IP: CCI vs. LFPI p=0.1; CT: CCI 
vs. LFPI p=0.5) (Figure 3.11). In the ipsilateral and contralateral outer 1/3 GCL, we did 
not find a statistical difference in DCX positive cells in the three groups (IP: p=0.878; 
CT: p=0.996) (Figure 3.11).  
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Figure 3.11. Migration of neuroblasts at 3 months after injury in the dentate gyrus. 
In sham and injured animals, majority of the DCX positive cells of the GZ were located 
in the (A) SGZ plus inner 1/3 GCL, with a significantly higher number of DCX positive 
cells in Sham animals compared to injured animals (IP: sham vs. CCI p=0.001, sham vs. 
LFPI, p=0.002; CT: sham vs. CCI p=0.011, sham vs. LFPI, p=0.018). In the (B) middle 
1/3 GCL, Sham animals had a significantly higher number of DCX positive cells 
compared to injured animals (IP: sham vs. CCI p=0.011, sham vs. LFPI, p=0.001; CT: 
sham vs. CCI p=0.026, sham vs. LFPI, p=0.008). In the (C) outer 1/3 GCL, there was no 
difference in the number of DCX positive cells between any group. 
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Experiment 3.  Factors Which Are Associated to Post-TBI Neurogenesis  
From experiments 1 and 2, our results indicate that TBI does not have an effect on 
the level of proliferation in the subacute and chronic-TBI stage. However, we did find 
that TBI does reduce the level of new neuron generation in the chronic stage, which is 
opposite of that in the subacute TBI stage. To investigate mechanisms that maybe 
associated to this change in neurogenesis in the chronic TBI stage, we examined 
neuroinflammatory responses of subacute and chronic TBI. We used two TBI animal 
models, CCI injury and LFPI, to study focal and diffuse injury effects at 15 days after 
injury and 3 months after injury. Inflammatory response was examined by markers for 
microglial activation in the brain. We used ED1 antibody to label ED1 proteins expressed 
in activated microglia that become phagocytic in the rat CNS during an inflammatory 
response (Damoiseaux et al., 1994). We also used the OX6 (anti-MHC class II) antibody 
to identify immunoreactive cells in the CNS. We checked for inflammation in the cortex, 
dentate gyrus, and thalamus.  
 
Inflammation in subacute-TBI 
At 15 days after injury, sham animals showed only scant amount of inflammation 
in the brain as detected by ED1 staining in the thalamus and OX6 staining in the DG. 
However, using both inflammatory markers, we show that injured animals had a 
significant inflammatory response in the ipsilateral side of injury in the cortex, dentate 
gyrus, and thalamus (Figure 3.12). 
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ED1 staining in the cortex revealed that CCI injured animals had a staining 
optical density of 10% +/- 1.8%, LFPI animals had a staining optical density of 14.5% +/- 
11%, and both injury groups were not significantly different from each other (p=0.531) 
(Figure 3.13). In the dentate gyrus, CCI injured animals had a staining optical density of 
4.7% +/- 3.3%, LFPI animals had a staining optical density of 0.57% +/- 0.28%, and both 
injury groups were significantly different from each other (p=0.002) (Figure 3.13). In the 
thalamus, sham animals had a staining optical density of 0.2% +/- 0.03%, CCI injured 
animals had a staining optical density of 2.7% +/- 1.8%, LFPI animals had a staining 
optical density of 9.3% +/- 1.17%. Both injury groups had significantly more 
inflammation in the thalamus compared to sham (sham vs. CCI, p<0.038; sham vs. LFPI, 
p<0.001) and both injury groups were significantly different from each other (p<0.001) 
(Figure 3.13). Both injury groups produced different inflammatory responses in the 
ipsilateral dentate gyrus and thalamus, with CCI injured animals having a more ED1 
staining in the dentate gyrus and LFPI animals having more ED1 staining in the 
thalamus.   
 
Similar trends were found with OX6 staining. In the cortex, CCI injured animals 
had a staining optical density of 2.3% +/- 0.98%, LFPI animals had a staining optical 
density of 12.5% +/- 9.9%, and both injury groups were significantly different from each 
other (p=0.016) (Figure 3.14). In the dentate gyrus, sham animals had a staining optical 
density of 0.29% +/- 0.29%, CCI injured animals had a staining optical density of 5.3% 
+/- 2.4%, LFPI animals had a staining optical density of 1.8% +/- 1.57%. Although both 
injury groups showed a greater inflammatory response in the DG compared to sham, only 
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CCI injury group had a statistically significant increase (sham vs. CCI, p=0.004; sham vs. 
LFPI, p=0.325). Also, both injury groups were significantly different from each other 
(p=0.017) (Figure 3.14). In the thalamus, CCI injured animals had a staining optical 
density of 11.3% +/- 2.76%, LFPI animals had a staining optical density of 26% +/- 
1.76%, and both injury groups were significantly different from each other (p<0.001) 
(Figure 3.14). Both injury groups produced different inflammatory responses in the 
ipsilateral cortex, dentate gyrus, and thalamus, with CCI injured animals having a more 
OX6 staining in the dentate gyrus, and LFPI animals having more OX6 staining in the 
cortex and thalamus. 
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Figure 3.12. ED1 and OX6 Staining Patterns In the Injured Brain. The top panel of 
images shows ED1 inflammatory marker expression in the cortex, dentate gyrus, and 
thalamus brain regions after CCI injury or LFPI. The bottom panel of images shows OX6 
inflammatory marker expression in the cortex, dentate gyrus, and thalamus brain regions 
after CCI injury or LFPI. Both inflammatory markers show inflammation in the injured 
brains. There is a noticeable difference of inflammatory responses between CCI injury 
and LFPI, with CCI injury producing more inflammation in the dentate gyrus, and LFPI 
producing more inflammation in the thalamus.  
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Figure 3.13. ED1 staining optical density at 15 days after injury. Optical density of 
ED1 staining was used to measure level of inflammation in the (A) cortex, (B) dentate 
gyrus, and (C) thalamus in sham and injured animals. Sham animals did not show ED1 
staining in the cortex and DG and had scant inflammation in the thalamus. Animals of 
both types of injuries showed inflammation in all ipsilateral structures. CCI injury 
animals had significantly more inflammation in the dentate gyrus compared to LFPI 
animals (p=0.002). LFPI animals had significantly more inflammation in the thalamus 
compared to CCI injury animals (p<0.001). 
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Figure 3.14. OX6 staining optical density at 15 days after injury. Optical density of 
OX6 staining was used to measure level of inflammation in the (A) cortex, (B) dentate 
gyrus, and (C) thalamus in sham and injured animals. Sham animals did not show OX6 
staining in the cortex and thalamus and had scant inflammation in the DG. Animals of 
both types of injuries showed inflammation in all ipsilateral structures. CCI injury 
animals had significantly more inflammation in the dentate gyrus compared to LFPI 
animals (p=0.017). LFPI animals had significantly more inflammation in the cortex 
(p=0.016) and thalamus (p<0.001) compared to CCI injury animals. 
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Inflammation in Chronic-TBI 
At 3 months after injury, using both inflammatory markers we assessed 
inflammatory responses in sham and injured animals. Injured animals showed more 
inflammation compared to sham animals.  In the cortex, sham animals did not show ED1 
staining. In the ipsilateral cortex, CCI injured animals had a staining optical density of 
4.55% +/- 1.73%, LFPI animals had a staining optical density of 6.38% +/- 4.88%, and 
both injury groups were not significantly different from each other (p=0.507) (Figure 
3.15). In the ipsilateral dentate gyrus, sham animals had a staining optical density of 
0.16% +/- 0.03%, CCI injured animals had a staining optical density of 1.25% +/- 0.13%, 
and LFPI animals had a staining optical density of 0.56% +/- 0.1%. Both injury groups 
had significantly more inflammation in the dentate gyrus compared to sham (sham vs. 
CCI, p<0.001; sham vs. LFPI, p=0.004) and CCI injury group had significantly more 
inflammation compared to LFPI group (CCI vs. LFPI, p<0.001). Although ED1 staining 
was detected in the contralateral dentate gyrus in sham and injured groups, One-Way 
Anova comparison of the three groups showed no significant difference (p=0.604) 
(Figure 3.15). In the ipsilateral thalamus, sham animals had a staining optical density of 
0.42% +/- 0.07%, CCI injured animals had a staining optical density of 1.22% +/- 0.22%, 
and LFPI animals had a staining optical density of 3.94% +/- 2.19%. LFPI group had 
significantly more inflammation in the thalamus compared to sham and CCI injury group 
(sham vs. LFPI, p=0.026; CCI vs. LFPI, p=0.032;), and CCI injury group was not 
significantly different from sham (p=0.542). Although ED1 staining was detected in the 
contralateral thalamus in sham and injured groups, One-Way ANOVA comparison of the 
three groups showed no significant difference (p=0.739) (Figure 3.15). 
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We also checked for inflammation in these brain regions with OX6 marker at 3 
months after injury (Figure 3.16). In the cortex, sham animals did not show OX6 
staining. In the ipsilateral cortex, CCI injured animals had a staining optical density of 
3.08% +/- 1.61%, LFPI animals had a staining optical density of 3.7% +/- 3.5 %, and 
both injury groups were not significantly different from each other (p=0.76). In the 
contralateral cortex, OX6 staining was detected with both injury groups having 
significantly more inflammation compared to sham (sham vs. CCI, p=0.035; sham vs. 
LFPI, p=0.001) and LFPI group had significantly more inflammation compared to CCI 
injury group (CCI vs. LFPI, p=0.002). In the dentate gyrus, sham and injured animals 
showed OX6 staining, however, using One-Way ANOVA to compare all three groups, 
we found no significant difference in ipsilateral and contralateral sides (IP: p=0.686; CT: 
p=0.819). In the ipsilateral thalamus, sham animals had a staining optical density of 
0.22% +/- 0.19%, CCI injured animals had a staining optical density of 0.2% +/- 0.08%, 
and LFPI animals had a staining optical density of 1.24% +/- 0.31%. LFPI group had 
significantly more inflammation in the ipsilateral thalamus compared to sham and CCI 
injury group (sham vs. LFPI, p<0.001; CCI vs. LFPI, p<0.001;), and CCI injury group 
was not significantly different from sham (p=0.936).  
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Figure 3.15. ED1 staining optical density at 3 months after injury. Optical density of 
ED1 staining was used to measure level of inflammation in the (A) cortex, (B) dentate 
gyrus, and (C) thalamus in sham and injured animals. Injured animals showed 
significantly more inflammation in ipsilateral cortex, dentate gyrus, and thalamus, 
compared to sham animals. CCI injury animals had significantly more inflammation in 
the dentate gyrus compared to LFPI animals (p<0.001). LFPI animals had significantly 
more inflammation in the thalamus compared to CCI injury animals (p=0.032). 
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Figure 3.16. OX6 staining optical density at 3 months after injury. Optical density of 
OX6 staining was used to measure level of inflammation in the (A) cortex, (B) dentate 
gyrus, and (C) thalamus in sham and injured animals. Injured animals showed 
significantly more inflammation in the ipsilateral and contralateral cortex, and only LFPI 
group showed significantly more inflammation in ipsilateral thalamus, compared to sham 
animals.  
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Experiment 4. Morphological Changes of the Hippocampus in Chronic-TBI. 
Apart from cellular changes that happen after TBI, morphological changes of 
overall brain structures such as the hippocampus have also been evaluated to assess 
injury characteristics. The purpose of this experiment was to evaluate TBI-induced 
morphological changes of the hippocampus in chronic-TBI stage using different TBI 
animal models. The CCI and LFPI models were used to compare changes of the 
hippocampal size after injury. The parameters of ipsilateral and contralateral hippocampi 
were measured in injured and sham animal groups. Percent change was calculated by 
taking a percentage of the ratio of ipsilateral to contralateral parameters.  
 
In our results we found that only animals that received LFPI show reduction of 
hippocampal size at 3 months after injury (Figure 3.17). These animals had a 12% +/- 
7.64% reduction of ipsilateral hippocampal size (Figure 3.18). Animals that received 
CCI injury and sham animals did not show changes in hippocampal size. Using One-Way 
ANOVA to compare change in all groups, we found that there is a statistically significant 
change (p=0.047). A post hoc LSD pairwise comparison, reveled that animals that 
received LFPI had statistically reduced ipsilateral hippocampal size compared to sham 
and CCI (Sham vs. LFPI, p=0.047; CCI vs. LFPI, P=0.027). Sham animals and CCI 
injury animals were not statistically different (p=0.894). 
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Figure 3.17. TBI-induced hippocampal size change at 3 months after injury. We 
observed the ipsilateral and contralateral hippocampal size differences of sham, CCI 
injury, and LFPI animal groups (scale bar= 900 µm). In sham animals, ipsilateral and 
contralateral hippocampal sides were similar in size. In CCI injury animals, ipsilateral 
hippocampus showed changes in shape but not in size compared to contralateral 
hippocampus. In LFPI animals, we found observable reduction in ipsilateral hippocampus 
size compared to contralateral hippocampus.  
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Figure 3.18. Quantification of hippocampal size change at 3 months after injury. 
Percentage of the ratio of ipsilateral to contralateral hippocampus perimeter reveals the 
injury-induced change in ipsilateral hippocampal size. CCI injury animals and sham 
animals do not have a change in ipsilateral hippocampus size. Only animals that received 
LFPI show a reduction of ipsilateral hippocampal size with an average percent ratio of 
88% +/- 7.64%, which is significantly different from sham animals (p=0.047) and CCI 
injury animals (p=0.027). 
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Chapter 4 - Discussion 
TBI poses significant short and long-term challenges to millions of people around 
the world (Zaloshnja et al., 2008). According to the CDC, majority of these patients are 
either younger than 24 years old or over 65 years old. Clinical evaluations have shown 
that TBI patients are more likely to develop many other neurological complications over 
time than people without a TBI history (Koponen et al., 2002). Recently much attention 
has been drawn to the relationship between TBI and dementia, as TBI patients commonly 
develop neurodegenerative diseases later in life such as Alzheimer’s and CTE (Smith et 
al., 2013). Over the past few decades we have learned a great deal about the mechanisms 
that regulate TBI, however, a central question still remains unanswered; what is causing 
these long-term TBI deficits?  
 
One possibility could be that there is a change in adult neurogenesis in the chronic 
TBI stage. In the past few decades we have discovered evidence of lifelong adult 
neurogenesis, mainly in the SVZ and DG of the mammalian brain (Sun, 2016). Our lab 
and many others have demonstrated that adult neurogenesis can be stimulated and one of 
these stimuli is TBI (Sun et al., 2005; Gao and Chen, 2013). Following TBI, the brain 
initiates endogenous neurogenic responses in an attempt to repair the physical damages. 
Some studies suggest that TBI induced neurogenesis in the DG contributes to the short-
term spontaneous cognitive recovery seen in clinical patients (Sun et al., 2015; León-
Carrión and Machuca-Murga, 2001). Because the hippocampus is linked to cognitive 
function and memory consolidation, TBI induced cellular changes in this structure may 
explain cognitive and behavioral changes seen in TBI patients (Deng et al., 2009). 
	 94	
However, the neurogenic stimulus following injury is not continuous and does not fully 
repair the damages. Majority of these studies have focused on acute and subacute 
neurogenic changes following TBI. For this reason, we investigated the neurogenic 
changes from subacute to chronic-TBI stage, and the mechanisms that may regulate long-
term neurogenic changes.    
 
Summary of Results 
To accurately study neurogenic responses after TBI, we used two different TBI 
animal models. Previous studies have reported conflicting results of TBI-induced 
neurogenic responses, particularly regarding cell differentiation and generation of new 
neurons (Sun et al., 2005; Kleindienst et al., 2005; Kernie et al., 2001; Rice et al., 2003; 
Gao and Chen, 2013). Some of these differences may be due to the use of different TBI 
animal models. Because TBI is a complex process involving both focal and diffuse 
injury, we used CCI and LFPI models to induce focal and diffuse injuries respectively, 
and bring attention to any differences that can be attributed to using different animal 
models. Brain tissue was collected 15 days after injury to evaluate subacute TBI, and 3 
months after injury to evaluate chronic TBI.  
 
In the subacute stage, TBI had no effect on the rate of proliferation in the GZ and 
hilus region. However, DCX immunolabeling showed that TBI induced an increase in the 
number of immature neurons in the ipsilateral side of injury in the GZ and hilus region. 
Further analysis showed that CCI injury resulted in more immature neurons in the hilus 
	 95	
than LFPI injury. Analysis of neural migration in the GZ revealed that TBI does cause 
more lateral migration but this is specific to focal injury induced by the CCI model.  
 
In the chronic stage of TBI, proliferation was no different after injury compared to 
sham, similar to what we found in the subacute stage. Interestingly however, we found a 
significant reduction in the generation of new neurons at 3 months after injury in the 
ipsilateral and contralateral granular zone. In the hilus region a significant reduction was 
seen only in the diffuse injury model in the ipsilateral side of injury. Neuronal migration 
in the GZ was also reduced in chronic-TBI stage; however, this was only seen in the 
middle 1/3 of the GCL.  
 
To investigate the mechanisms that may regulate the activity of generating new 
neurons in chronic-TBI, we examined neuroinflammation in the cortex, DG, and 
thalamus at both subacute and chronic-TBI stage. In the subacute-TBI stage, 
inflammation was seen only in the ipsilateral hemisphere of injured animals while sham 
animals show no inflammatory responses. Also, CCI injury model induces a significantly 
higher inflammatory response in the DG, while LFPI model induces a higher 
inflammatory response in the thalamus, which is indicative of focal injury caused by CCI 
model and diffuse injuries caused by LFPI model. In the chronic stage of TBI, we found a 
similar trend in inflammatory response. We found low levels of inflammation in the DG 
and thalamus of sham animals and significantly higher inflammatory responses in injured 
animals in cortex, DG, and thalamus. These inflammatory results indicate that TBI-
induced inflammation is persistent long after TBI injury.  
	 96	
 
Further assessment of TBI induced changes in chronic stage involved 
morphological analysis of the hippocampus. Our results indicate a changed morphology 
of the hippocampus after injury that can be seen at 3 months after injury. CCI injury 
model produced an observed change in shape of the ipsilateral hippocampus while LFPI 
model caused shrinkage of the ipsilateral hippocampus.  
 
Subacute-TBI neurogenic response  
The TBI-induced neurogenic response involves all aspects of neurogenesis 
including proliferation, differentiation, survival and integration (Sun, 2016). Our lab and 
others have shown that TBI-induced proliferative activity peaks at 2 days post injury and 
gradually returns to baseline by 14 days post injury (Sun et al., 2005; Gao and Chen, 
2013). In this study, at 15 days after injury, we found baseline proliferation levels in 
injured animals, consistent with previous reports. However, the ability of TBI to 
stimulate an endogenous neurogenic response in the brain has been controversial. Most 
studies agree that TBI induces an up-regulation in proliferation in the DG and SVZ (Sun 
et al., 2005; Gao and Chen, 2013). However, discrepancies arise in discussion about the 
fate of these newly proliferated cells. Some studies report that increased proliferation in 
the neurogenic regions results in several fold increase of the number of new neurons that 
can be seen as long as 60 days post injury (Sun et al., 2005; Kleindienst et al., 2005; 
Kernie et al., 2001; Richardson et al., 2007). Other studies have found that TBI does not 
change the production of new neurons (Rice et al., 2003; Gao and Chen, 2013) or may 
even have a reductive effect on neuronal production (Rola et al., 2006). These 
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discrepancies may be due to many factors including different injury models used, 
assessment at different post injury time points, quantification methods, and/or human 
error. In our results, we found that at 15 days after injury using either CCI or LFPI model, 
TBI causes a significant increase in the number of immature neurons in the ipsilateral DG 
of the adult rat brain. This is in disagreement with another study that used similar 
approach, looking at the number of DCX positive cells after injury, to assess TBI-induced 
generation of immature neurons, in which they report a significant decrease (Rola et al., 
2006). The difference in results may be due to different animals used as their study used 
mice. Also, cell counting methods were different as they only examined the number of 
DCX positive cells in the SGZ, excluding a major portion of cells that may have migrated 
into the inner 1/3 GCL after injury. Other studies that have shown a TBI-induced increase 
in the generation of new neurons, have not directly analyzed cell counts of immature 
neurons after injury.  
 
Chronic-TBI Neurogenic Response 
TBI-induced proliferation involves a robust increase in cell divisions of NSC into 
more NSCs and NPCs (Sun et al., 2005; Bonaguidi et al., 2012). We hypothesized that 
the acute-TBI neurogenic stimulus would exhaust the NSC pool through rapid 
symmetrical differentative cell divisions, where one NSC divides into two NPCs, 
resulting in reduced proliferative activity over time. Our proliferation results using both 
pulse BrdU paradigm and Ki67 staining at 3 months after injury however, did not match 
our expectations, as we did not find a reduction of proliferative activity in chronic TBI, 
indicating that the NSC pool may not be exhausted over time. Our results are inconsistent 
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with a previous study that reported reduction of proliferating cells 2 month after injury 
(Acosta et al., 2013). Although they used similar TBI model and immunohistochemical 
staining procedures, their cell counting method involved only examining the number of 
Ki67 positive cells in the SGZ, whereas we included proliferating cells of the entire 
granular zone.  
 
To fully understand chronic-TBI impact on neurogenesis, we also looked at the 
generation of new neurons at 3 months after injury. Although proliferative activity is not 
impacted by TBI in the chronic stage, our results show significant reduction in the 
number of DCX positive cells, suggesting that TBI causes a long-term reduction in the 
ability to generate new neurons in the DG. Studies have suggested that chronic 
neuroinflammation may negatively regulate adult neurogenesis (Gao and Hong, 2008). In 
a rodent TBI study, sustained neuroinflammation was detected more than 8 weeks post-
injury and showed hippocampal cell loss and down-regulation of proliferation in the SGZ 
of the hippocampus when compared to sham animals (Acosta et al., 2013). Considering 
that TBI-stimulated hippocampal proliferation returns to baseline levels by 14 days post-
injury, at 8 weeks post-injury the baseline neurogenic stimulus may not be strong enough 
to overcome the negative effects of chronic-neuroinflammation, which could result in 
decreased neurogenesis below baseline levels in the chronic-TBI stage. One study shows 
that increasing the stimulation of neurogenesis through environmental enrichment and 
exercise rescues the neurogenic suppression via lipopolysaccharide-induced 
inflammatory conditions (Wu et al., 2007). This suppression of neurogenic activity via 
inflammatory responses would also explain many of the long-term pathological 
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conditions of chronic-TBI that are reported after injury such as neurodegenerative 
diseases, psychiatric disorders, and sleep disorders. These findings indicate that TBI-
induced inflammatory responses may be active at 3 months post-injury, affecting the 
normal neurogenic activity.  
 
TBI-induced Inflammation Affects Long-term Neurogenesis 
Concurrent with stimulated neurogenic activity that induces benefits following 
TBI, studies show that other TBI induced mechanisms are also activated that are 
detrimental to recovery and normal function such as progressive cell death and 
inflammation in the brain (Bramlett and Dietrich, 2015). Especially in the hippocampus, 
these mechanisms can be responsible for some of the cognitive deficits, sensory and 
motor dysfunction, and neuropathology such as seizures seen in TBI patients (Fujimoto et 
al., 2004; Gupta and Gupta, 2005). Studies have found significant cell death in the DG 
after acute-TBI, especially of immature neurons (Gao et al., 2008). Inflammatory 
responses after injury have been demonstrated to play a role in the regulation of 
hippocampal cell death and reduced neurogenic activity through activation of microglia 
that release inflammatory mediators such as IL-1, IL-6, TNF-α, reaction oxygen species 
etc. (Monje et al., 2003; Ekdahl et al., 2003). These pro-inflammatory mediators are 
detrimental for survival of newly generated neurons (Ekdahl et al., 2003). For example, 
studies have shown that the number of activated microglia and the levels of pro-
inflammatory cytokines, particularly IL-6 and TNF-α, produced by microglia are 
correlated with decreased survival of new hippocampal neurons, and inhibition of 
microglia activation with anti-inflammatory drug treatment increase the number of newly 
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formed neurons (Monje et al., 2003; Ekdahl et al., 2003). It is likely that the persistent 
inflammation following TBI, especially after the TBI-induced acute neurogenic stimulus 
is returned to baseline, curtail the neuronal differentiation or survival of newly generated 
cells. Future study using combination of BrdU with cell type specific markers is needed 
to answer this question. In this study we found inflammatory responses during subacute-
TBI, and this inflammation is persistent at 3 months after injury. In a previous study, 
TBI-induced inflammatory responses have been detected in the striatum, thalamus, and 
cerebral peduncle at 2 months after injury in conjunction with reduced levels of immature 
neurons in the SGZ (Acosta et al., 2013). Our study adds to these findings showing that 
inflammatory responses are extended to 3 months post injury and also detected in the DG 
and cortex regions, concomitant with reduction of immature neurons in the DG.  
 
Hippocampal morphological changes following TBI  
Apart from cellular and biochemical changes, chronic assessment of TBI also 
involves morphological changes. Temporal studies of histopathological changes after TBI 
in rats demonstrate progressive cell death mechanisms in the cerebral cortex and 
hippocampus over one year after injury (Smith et al., 1997). These cell death mechanisms 
have also been linked to neurodegenerative changes.  Clinical studies show changes in 
white matter tracts and progressive atrophic changes in TBI patients at one year after 
injury (Williams et al., 2001; MacKenzie et al., 2002). The hippocampus is particularly 
vulnerable to TBI as evident from morphological changes seen in the temporal lobe, 
specifically hippocampal atrophy (Ariza et al., 2006). In the present study we found TBI-
induced morphological changes of the hippocampus; particularly in the LFPI model at 3 
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months post-injury we found shrinkage of the hippocampus. This is consistent with 
previous findings showing reduced hippocampal volume at 2 months following LFPI in 
rats (Bramlett et al., 1997). Studies suggest that these morphological changes may 
contribute to cognitive and behavioral changes seen in many TBI patients (Jorge et al., 
2007). Atrophy of the hippocampus may also be a contributing factor to the chronic 
changes of adult neurogenesis that we found in this study.   
 
Conclusion and Future Direction  
TBI induces both acute and chronic neurological consequences that can lead to 
pathological conditions such as cognitive deficits, neurodegenerative diseases, psychiatric 
disorders, and seizures among many other problems (Koponen et al., 2002; Castriotta et 
al., 2007; Uryu et al., 2007). The complex interplay of mechanisms that regulate these 
acute and chronic conditions is not completely understood. The present study in 
combination with previous studies shows involvement of a neurogenic response to TBI, 
in an endogenous effort to initiate brain repair mechanisms (Sun, 2016; Sun et al., 2005). 
This endogenous neurogenic response is stronger than the normal baseline adult 
neurogenic activity, however, it is not continuous (Sun et al., 2005). Once this TBI-
induced neurogenic response returns to baseline levels, other persistent TBI induced 
mechanisms may affect normal adult neurogenic activity. In the present study we show 
the involvement of inflammatory mechanisms that may regulate normal neurogenic 
activity in chronic-TBI. Our study shows persistent inflammation concurrent with 
reduced generation of immature neurons in chronic TBI stage.  
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Further investigation is required to understand the true nature of this interaction 
between chronic inflammation and reduced neurogenic activity. It is also necessary to 
elucidate the phenotype of microglial activation in chronic-TBI. Studies have shown that 
specific microglial phenotypes have specialized functions, such as the M1 phenotype that 
has pro-inflammatory properties and the M2 phenotype that has anti-inflammatory 
properties (Hsieh et al., 2013). Distinguishing the phenotype of microglia activation will 
determine the nature of the inflammatory response in chronic stage of TBI.   
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